Clinical trial
Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans
NCT00246714 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00246714 |
|---|---|
| Title | Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans |
| Official title | Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Endotoxemia |
| Intervention type | Drug |
| Interventions | repeated injections of endotoxin during 5 days |
| Enrollment | 16 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Oct 31, 2005 |
| Last update posted | Apr 15, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: